MedTrace Logo

Microcirculation in Patients With Leukemic Hyperleukocytosis

NCT03729206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2022-11-07

No results posted yet for this study

Summary

Hyperleukocytosis in patients with acute leukemia impacts rheology and microvascularization, leading to severe symptoms or even death. The investigators investigated whether blood stream alterations induced by hyperleukocytosis can be detected by sidestream dark-field imaging and whether they correlate with the grade of symptoms.

Conditions

  • Hyperleukocytic Syndrome

Interventions

DIAGNOSTIC_TEST

intravital microscopy

intravital microscopy with sidestream dark-field imaging

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Christoph Schliemann, MD · University Hospital Muenster

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-12-01
Completion
2021-08-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03729206 on ClinicalTrials.gov